TELA Bio (TELA) Cash & Equivalents (QoQ) (2019 - 2026)
TELA Bio (TELA) Cash & Equivalents (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | TELA Bio | 36.24 Mn | 5.82 Mn | 13.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.06% |
| Mar 31, 2026 | -22.23% |
| Dec 31, 2025 | 71.12% |
| Sep 30, 2025 | -15.05% |
| Jun 30, 2025 | -18.34% |
| Mar 31, 2025 | -18.68% |
| Dec 31, 2024 | 204.43% |
| Sep 30, 2024 | -34.70% |
| Jun 30, 2024 | -28.66% |
| Mar 31, 2024 | -20.51% |
| Dec 31, 2023 | -19.71% |
| Sep 30, 2023 | -10.82% |
| Jun 30, 2023 | 116.66% |
| Mar 31, 2023 | -28.31% |
| Dec 31, 2022 | -22.51% |
| Sep 30, 2022 | 95.59% |
| Jun 30, 2022 | -16.03% |
| Mar 31, 2022 | -24.85% |
| Dec 31, 2021 | -18.09% |
| Sep 30, 2021 | -11.04% |